MedTechHub · Other Medical Devices · Asia Pacific

China Minimally Invasive Surgery Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The China minimally invasive surgery (MIS) devices market encompasses instruments, equipment, and accessories used in procedures that rely on small incisions rather than open surgery, including laparoscopic tools, endoscopes, energy devices, and robotic-assisted systems. Valued at approximately $3.5 billion in 2025, the market is projected to expand at a compound annual growth rate of 23.0%, making it one of the fastest-growing medical device segments in the Asia Pacific region. This rapid expansion is driven by rising healthcare expenditure, an aging population with greater prevalence of chronic conditions requiring surgical intervention, and China's ongoing efforts to modernize hospital infrastructure with advanced surgical technologies. Government policies promoting domestic medical device manufacturing, along with increasing surgeon training and hospital adoption of minimally invasive techniques, are further accelerating market development.

Market size · 2025
$3.5 billion
CAGR · 2025–2030
23%
Forecast · 2030
$9.9 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $3.5bn2030 est: $9.9bn
Read the full China Minimally Invasive Surgery Devices Market report →

Market Overview

China's MIS devices market represents a critical component of the country's broader medical devices industry, which has grown substantially alongside national healthcare reforms and expanded insurance coverage. The market covers a wide array of product categories, including hand-held instruments, energy-based devices, visualization systems, and increasingly, robotic platforms. Hospitals across tier-1, tier-2, and tier-3 cities are gradually replacing conventional open surgery approaches with minimally invasive alternatives, driven by benefits such as reduced patient recovery time, lower complication rates, and shorter hospital stays.

  • The market encompasses laparoscopic instruments, endoscopes, energy devices, ablation systems, and robotic surgical platforms
  • Growth is supported by China's expanding hospital infrastructure and ongoing medical device localization policies
  • Recovery-time advantages and lower complication rates continue to drive surgeon and patient preference for MIS procedures

Growth Drivers

China's aging demographic profile is a fundamental growth catalyst, as the proportion of citizens over 65 continues to rise, increasing demand for surgical interventions related to cardiovascular disease, oncology, and orthopedic conditions. Rising per capita healthcare spending and expanded medical insurance reimbursement for advanced procedures have made MIS technologies more accessible to a broader patient population. Additionally, China's Made in China 2025 initiative and related policies actively encourage domestic production of high-end medical devices, reducing reliance on imports and creating opportunities for local manufacturers.

  • An aging population and higher prevalence of chronic diseases are increasing surgical procedure volumes across the country
  • Expanding medical insurance coverage and rising healthcare spending are improving patient access to advanced MIS procedures
  • Government incentives for domestic manufacturing and technology localization are accelerating local industry development
Want a deeper cut on China Minimally Invasive Surgery Devices Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is commonly segmented by product type, including hand-held devices, energy devices, laparoscopy devices, and robotic-assisted systems, with laparoscopy and hand-held instruments representing the largest volume segments. Geographically, tier-1 cities such as Beijing, Shanghai, and Guangzhou lead adoption due to concentrated high-end hospital facilities and greater surgeon familiarity with advanced MIS techniques. Tier-2 and tier-3 cities are emerging as significant growth markets as regional medical centers upgrade their surgical capabilities and expand minimally invasive service offerings.

  • Product segments include hand-held instruments, energy-based devices, laparoscopy equipment, and robotic surgical systems
  • Tier-1 cities dominate current adoption due to advanced hospital infrastructure and specialized surgical training programs
  • Tier-2 and tier-3 cities represent the fastest-growing regional segment as healthcare access continues to expand

Trends and Outlook

What are the recent trends and outlook?

Robotic-assisted minimally invasive surgery is emerging as a transformative trend in China, with hospitals increasingly investing in platforms that offer enhanced precision, tremor filtration, and improved surgeon ergonomics. Digital integration, including AI-assisted surgical planning, augmented reality visualization, and connected operating room ecosystems, is expected to shape product development over the coming years. With the market projected to sustain strong double-digit growth through the decade, continued expansion will depend on product innovation, pricing accessibility, and the ongoing professional development of surgical teams across China's diverse healthcare landscape.

  • Robotic-assisted surgery platforms are gaining traction as hospitals seek competitive differentiation and improved clinical outcomes
  • Digital integration and AI-assisted technologies are expected to influence next-generation MIS device development
  • Sustained growth will be driven by the combined forces of technological advancement, domestic manufacturing expansion, and broadening surgical adoption
Talk to a Claight analyst
Do you want to research China Minimally Invasive Surgery Devices Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.